间歇性禁食对2型糖尿病患者的代谢影响:系统综述与干预性研究荟萃分析
该系统综述与荟萃分析纳入7项随机饮食对照研究(n=338,平均BMI 35.65,平均基线HbA1c 8.8%),评估间歇性禁食(IF)对比标准饮食对2型糖尿病(T2DM)患者的代谢影响。结果显示IF较标准饮食额外减轻体重1.89 kg(95%CI -2.91至-0.86 kg),但HbA1c无进一步降低(-0.11%,95%CI -0.38%至0.17%)。
要点
- IF较标准饮食额外减重1.89 kg,BMI>36人群减重更明显(-3.43 kg)。
- IF未较标准饮食进一步降低HbA1c(差值-0.11%,无统计学意义)。
- IF可作为T2DM患者减重策略,但降糖获益与标准饮食相当。
核心结论
- 当前证据表明,IF较标准饮食与T2DM患者更大的体重下降相关,但血糖控制影响相似。
研究设计与样本
- 系统综述与荟萃分析,检索Embase、PubMed和clinicaltrials.gov(1950年至2020年8月12日)。
- 纳入7项随机饮食对照研究,共338名T2DM成人,平均BMI 35.65,平均基线HbA1c 8.8%。
- 采用随机效应模型计算体重和HbA1c的绝对差异合并估计值。
主要发现
- BMI>36的研究中IF额外减重-3.43 kg(95%CI -5.72至-1.15 kg)。
- 持续时间≤4个月的研究中IF额外减重-3.73 kg(95%CI -7.11至-0.36 kg)。
- IF较标准饮食未进一步降低HbA1c(-0.11%,95%CI -0.38%至0.17%)。
临床怎么用
- 对于超重或肥胖的T2DM患者,IF可作为减重策略选择,但不应期望其带来额外降糖获益。
- 在BMI较高(>36)患者中IF减重效果可能更明显,但需注意研究持续时间较短的影响。
局限性
- 纳入研究数量较少(7项),总样本量338例,证据强度有限。
- 研究间IF方案和饮食对照可能存在差异,可能影响结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Intermittent fasting (IF) has been proposed as a weight-loss strategy with additional cardiometabolic benefits in individuals with obesity. Despite its growing popularity, the effect of IF in patients with type 2 diabetes (T2DM) remains unclear. OBJECTIVE: We conducted a systematic review and meta-analysis to evaluate the metabolic impact of IF compared to standard diet in patients with T2DM. METHODS: Embase, PubMed, and clinicaltrials.gov between 1950 and August 12, 2020 were searched for randomized, diet-controlled studies evaluating any IF intervention in adults with T2DM. We examined the impact of IF on weight loss and glucose-lowering by calculating pooled estimates of the absolute differences in body weight and glycated hemoglobin A1c (HbA1c) compared to a control group using a random-effects model. RESULTS: Seven studies (n = 338 participants; mean body mass index [BMI] 35.65, mean baseline HbA1c 8.8%) met our inclusion criteria. IF induced a greater decrease in body weight by -1.89 kg (95% CI, -2.91 to -0.86 kg) compared to a regular diet, with no significant between-study heterogeneity (I2 21.0%, P = .28). The additional weight loss induced by IF was greater in studies with a heavier population (BMI > 36) (-3.43 kg [95% CI, -5.72 to -1.15 kg]) and in studies of shorter duration (≤ 4 months) (-3.73 kg [95% CI, -7.11 to -0.36 kg]). IF was not associated with further reduction in HbA1c compared to a standard diet (HbA1c -0.11% [95% CI, -0.38% to 0.17%]). CONCLUSION: Current evidence suggests that IF is associated with greater weight loss in patients with T2DM compared with a standard diet, with a similar impact on glycemic control.
引用
- Borgundvaag E, Mak J, Kramer CK, et al. Metabolic Impact of Intermittent Fasting in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Interventional Studies. J Clin Endocrinol Metab. 2021. PMID: 33319233. doi:10.1210/clinem/dgaa926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。